topic

170 Scalable detection of virus RNA in tumors – effective targets for new therapies
Gitte Pedersen

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A194; DOI: 10.1136/jitc-2023-SITC2023.0170
171 Scalable liquid biopsy assay for treatment selection and MRD detection in lymphoma and its validation in novel live cell assays
Gitte Pedersen, Morten Pedersen

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A195; DOI: 10.1136/jitc-2023-SITC2023.0171
172 Cancer immunotherapy response monitoring with whole blood immuno-transcriptomic profiling
Pedro Romero, Laura Ciarloni, Noushin Hadadi, Rutger Koornstra, Sandra van Wilpe, Eric Durandau, Sahar Hosseinian Ehrensberger, Sylvain Monnier-Benoit, Niven Mehra

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A196; DOI: 10.1136/jitc-2023-SITC2023.0172
174 Introducing molecular pixelation unraveling the changes in spatial distribution of immune cell surface proteins upon treatment with rituximab
AnnaLotta Schiller Vestergren, Annika Branting

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A198; DOI: 10.1136/jitc-2023-SITC2023.0174
175 Metastatic triple negative breast cancer has distinct tumor immune landscape
Robert Seager, Heidi Ko, Sarabjot Pabla, Maria-Fernanda Senosain, Erik Van Roey, Shuang Gao, Kyle C Strickland, Rebecca A Previs, Mary K Nesline, Stephanie B Hastings, Shengle Zhang, Jeffrey M Conroy, Taylor J Jensen, Marcia Eisenberg, Brian Caveney, Eric A Severson, Shakti Ramkissoon, Shipra Gandhi

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A199; DOI: 10.1136/jitc-2023-SITC2023.0175
176 Immune microenvironment of primary versus metastatic melanoma of the brain
Maria-Fernanda Senosain, Heidi Ko, Sarabjot Pabla, Robert Seager, Erik Van Roey, Shuang Gao, Kyle C Strickland, Rebecca A Previs, Mary K Nesline, Stephanie B Hastings, Shengle Zhang, Jeffrey M Conroy, Taylor J Jensen, Marcia Eisenberg, Brian Caveney, Eric A Severson, Shakti Ramkissoon

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A200; DOI: 10.1136/jitc-2023-SITC2023.0176
177 Exploring the relationship between tumour heterogeneity and response to immunotherapy in malignant pleural mesothelioma
Dmitrii Shek, Bo Gao, Hema Mahajan, Adnan Nagrial, Matteo Carlino, Fabio Luciani, Scott Read, Golo Ahlenstiel

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A201; DOI: 10.1136/jitc-2023-SITC2023.0177
178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy
Urminder Singh, Christian E Laing, Jacob Gibson, Anna Kluew, Mahdi Golkaram, Sven Bilke, Larissa Pikor, Nathalie Brassard, Matthew Beatty, Doris Wiener, Brian Czerniecki, Shari Pilon-Thomas, Simon Turcotte, Li Liu, Stewart E Abbot, Timothy J Langer, Grace DeSantis, Michael J Ciancanelli, Jeff H Tsai

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A202; DOI: 10.1136/jitc-2023-SITC2023.0178
179 Profiling microsatellite instability using RNA sequencing data
Sukhi Singh, Janez Kokosar, Jan Otonicar, Luka Ausec

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A203; DOI: 10.1136/jitc-2023-SITC2023.0179
180 Evaluation of association of mutation in ARID family of genes with outcomes in cutaneous melanoma
George P Souroullas, Tolulope Adeyelu, Andrew Elliott, Soo Park, Kevin Kim, Ari VanderWalde, George Ansstas

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (Suppl 1) A204; DOI: 10.1136/jitc-2023-SITC2023.0180

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages